Tyndall Capital Partners

Tyndall Capital Partners as of March 31, 2017

Portfolio Holdings for Tyndall Capital Partners

Tyndall Capital Partners holds 3 positions in its portfolio as reported in the March 2017 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Onconova Therapeutics 45.5 $1.6M 521k 3.04
Mma Capital Management 45.0 $1.6M 67k 23.25
Onconova Therapeutics Inc *w exp 07/07/202 9.4 $328k 391k 0.84